Pluri Inc. Common Stock (PLUR)
Pluri Inc. (PLUR) is a healthcare technology company focused on developing and commercializing digital solutions for personalized medicine. The company leverages artificial intelligence and advanced analytics to enhance laboratory testing and diagnostics, aiming to improve patient outcomes through tailored treatment options.
Company News
DarioHealth Corp. announced that its Chief Financial Officer, Zvi Ben-David, will retire on May 15, 2025. The company has appointed Chen Franco-Yehuda as the new CFO, Treasurer, and Secretary, effective upon Ben-David's retirement.
Pluri Inc., a biotechnology firm, is facing the possibility of being delisted from the Nasdaq Capital Market due to failing to meet the minimum stockholders' equity requirement. The company has submitted a compliance plan and has been granted an extension until November 2024 to regain compliance.
HAIFA, Israel, June 18, 2024 (GLOBE NEWSWIRE) -- Leading biotechnology company Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri” or the “Company”), which transforms cells into solutions that promote global wellbeing and sustainability, today announced strategic investments in Pluri’s subsidiary, Ever After Foods Ltd. (“Ever After Food...